Trial intelligence / Profile preview

Phase IV randomized double-blind trial of new-process versus old-process MMR vaccine in infants

CTR20211075Phase 4Active

Sponsor
Beijing Institute of Biological Products
Start
May 2021
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Measles, Mumps, and Rubella Vaccine Live in measles, mumps, rubella, sponsored by Beijing Institute of Biological Products. Started May 2021; status: active.

02

Drugs

Measles, Mumps, and Rubella Vaccine Live
03

Conditions

measlesmumpsrubella

Beyond the preview

Go deeper on CTR20211075.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20211075.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call